Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study
Survival of people with early onset type 1 diabetes has improved over time, whereas survival of people with late onset type 1 diabetes has deteriorated since the 1980s (BMJ)
The prickly problem of access to insulin
Insulin remains unaffordable in many countries even though it is no longer protected by patents. Deborah Cohen examines why (BMJ)
Metformin after Bariatric Surgery – an Acid Problem
Metformin use should therefore be critically reconsidered after bariatric operations (Experimental and Clinical Endocrinology & Diabetes )
Implications of Nocturnal Hypertension in Children and Adolescents With Type 1 Diabetes
This study showed significantly increased cIMT and daytime blood pressure in diabetic children and adolescents with nocturnal hypertension (Diabetes Care)
Brief Intensive Lifestyle Intervention Leads to Rapid Diabetes Improvements
This is one of the first studies to report rapid and significant HbA1c changes as a result of following moderate nutrition and physical activity guidelines while receiving diabetes management and weight loss psychoeducation (American Journal of Lifestyle Medicine)
Reducing Health Disparities Related to Diabetes
Lessons learned through the Canadian diabetes strategy Community based program (Public Health Agency, Canada)
Discovery of Dual-Action Membrane-Anchored Modulators of Incretin Receptors
These findings suggest that conversion of a recombinant MTL to a soluble membrane anchored equivalent offers a means to prolong ligand function, as well as to design agonists that can simultaneously act on more than one therapeutic target (PLoS)
Glucose biosensor for diabetes ‘shows high accuracy’
A human pilot study of a fully-implantable continuous glucose sensor has demonstrated high accuracy performance for the first time for an implanted biosensor (Hospital Pharmacy Europe)
Boehringer Ingelheim and EFSD collaborate to support diabetes research in Europe
A new partnership to establish a €2.5 million research grant programme, encouraging diabetes research over the next three years (World Pharma News)
Bydureon
Analyses Find Type 2 Diabetes Patients Treated with Bydureon™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 (Lilly)
Lantus leads to better glycemic control
Initiation of Lantus leads to better glycemic control at similar weight gain versus other comparators in patients with Type 2 Diabetes (Sanofi)
Lyxumia
Lyxumia (lixisenatide) One-Step Regimen as Effective as Two-Step Regimen in Improving Glycemic Control in Type 2 Diabetes (Sanofi)
Glycosmedia is also available as an App: